Leiden University
Risk of osteoarthritis associated with high production of interleukin
Published in Cancer Law Weekly, July 9th, 2005
"In a sibpair study of OA patients, we investigated whether, upon stimulation with lipopolysaccharide (LPS), variations in the innate ex vivo production of IL-1beta, IL-1 receptor antagonist (IL-1Ra), IL-10, and tumor necrosis factor alpha (TNF-alpha) in whole-blood assays contribute to the risk of OA. Data from 305 patients with OA at multiple sites (hand, knee, hip, and spine), whose median age was 60 years (range 43-79 years), were compared with those from 137 controls," scientists in the Netherlands...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2005-07-09)
More Articles from Cancer Law Weekly
- Aphton Corporation
Biotech company appoints Manfred Ruediger as chief operating officer - Avantogen
European patent grant for immune-enhancing adjuvant - Cel-Sci Corp.
U.S. patent allowed on pre-sensitizing cancer prior to treatment - European Society for Human Genetics
Geneticists oppose singling out Jewish women in European patent - Exelixis, Inc.
Collaboration to focus on therapeutics for cancer, inflammation, tissue repair - Kosan Biosciences
Trial of second-generation Hsp90 inhibitor in hematologic cancers initiated - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
